Announcing Speakers at the DIA 2012 Annual Meeting
RESTON, Va.--(BUSINESS WIRE)--Jun 20, 2012-- Aptiv Solutions, a biopharmaceutical and medical device development services company, and the leader in adaptive clinical trial design, simulation and execution, announced today that several of its thought leaders will provide new insights on the design and execution of adaptive trials at the upcoming Drug Information Association (DIA) 2012 Annual Meeting.
The meeting will be held on June 24-28, 2012 in Philadelphia, PA. More than 7,000 industry professionals are expected to attend.
Aptiv Solutions will showcase its adaptive clinical trial offering with the following presentations: -- Innovation Theater Presentation titled: "ADDPLAN PE- Innovative Software for Population Enrichment Designs in Adaptive Clinical Trials" Vladimir Dragalin, PhD, Senior Vice President, Clinical Trial Innovation StrategiesAptiv Solutions will give a demonstration of ADDPLAN(R) PE, the fully validated statistical software for the design, simulation and analysis of population enrichment trials on June 26 from 12:00 PM - 12:45 PM -- White Paper Showcase titled: "Implementation of Adaptive Clinical Trials" Vladimir Dragalin, PhD, Senior Vice President, Clinical Trial Innovation StrategiesMary Riggs, Senior Vice President, Global Operational ExcellenceJim Box, MS, MBA, Senior Director, Data ManagementAptiv Solutions will speak about adaptive trial specific SOPs, processes and work practices, and will provide a demonstration of AptivAdvantage(TM) - our integrated EDC/Randomization, drug supply and adaptive design engine technology solution on June 26 from 1:30 PM - 3:00 PM -- "Into Patients, Timely but Safely, Using Integrated and Adaptive Design Approaches" Session Chairperson & Speaker: John Shillingford, PhD, Vice President, Strategic Initiatives; June 26, 1:30 PM - 3:00 PM -- Developing and Utilizing Open Source Software for Clinical Drug Development in a Biopharma Industry Environment" Vladimir Dragalin, PhD, Senior Vice President, Clinical Trial Innovation Strategies;June 28, 9:00 AM - 10:30 AM "We created the adaptive trials Innovation Center at Aptiv Solutions a year ago, with the focused goal of developing a new paradigm in clinical trials" said, Patrick K. Donnelly, Chairman and CEO of Aptiv Solutions. "Today we are proud to showcase our latest advances including our newest statistical applications for patient enrichment in ADDPLAN(R) PE and our integrated platform, AptivAdvantage(TM), designed to meet the stringent requirements of adaptive trial execution. Both of these will be featured at our exhibit booth".
In addition, Aptiv Solutions experts will provide insights that contribute to bringing life science products to market more efficiently. The following topics will be addressed: -- "Agency Advice: Getting the Most From Your Meetings" Jenny Vestal, Global Director Regulatory Strategy; June 27, 10:00 - 11:30 AM -- "Drug Development Strategies and Incorporation of an Established Project Management System: Integrated Drug Development: Case Study" Session Chairperson & Speaker: Marija Ribar, DMD,MBA, Director, Product Development Consultancy; June 27, 1:30PM - 3:00PM -- "Evaluating Cost and Complexity of a GI Cancer Study Design Using an FDA Software Tool" Philip Dehazya, PhD, Program Director, Oncology Business Unit; June 28, 10:45 AM -12:15 PM For more information about Aptiv Solutions and its speakers, visit us at booth #2815 at the DIA Annual Meeting.
About Aptiv Solutions Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market. The company offers clients an extensive portfolio of innovative services including adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv Solutions has over 850 professionals in North America, Europe, the Middle East, and Japan.
Visit the website at www.aptivsolutions.com.
CONTACT: Aptiv Solutions Gillian DellaCioppa, +1-508-597-6000 Director of Marketing email@example.com KEYWORD: UNITED STATES NORTH AMERICA VIRGINIA INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL FDA GENERAL HEALTH SOURCE: Aptiv Solutions Copyright Business Wire 2012 PUB: 06/20/2012 04:00 AM/DISC: 06/20/2012 04:00 AM http://www.businesswire.com/news/home/20120620005186/